Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Lung Cancer

  Free Subscription

Articles published in PLoS Med

Retrieve available abstracts of 6 articles:
HTML format
Text format

Single Articles

    February 2018
  1. CRISS SD, Sheehan DF, Palazzo L, Kong CY, et al
    Population impact of lung cancer screening in the United States: Projections from a microsimulation model.
    PLoS Med. 2018;15:e1002506.
    PubMed     Text format     Abstract available

    April 2017
  2. TEN HAAF K, Jeon J, Tammemagi MC, Han SS, et al
    Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study.
    PLoS Med. 2017;14:e1002277.
    PubMed     Text format     Abstract available

    February 2017
  3. TEN HAAF K, Tammemagi MC, Bondy SJ, van der Aalst CM, et al
    Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada.
    PLoS Med. 2017;14:e1002225.
    PubMed     Text format     Abstract available

    Refining Lung Cancer Screening Criteria in the Era of Value-Based Medicine.
    PLoS Med. 2017;14:e1002226.
    PubMed     Text format     Abstract available

  5. HAMBLIN A, Wordsworth S, Fermont JM, Page S, et al
    Clinical applicability and cost of a 46-gene panel for genomic analysis of solid tumours: Retrospective validation and prospective audit in the UK National Health Service.
    PLoS Med. 2017;14:e1002230.
    PubMed     Text format     Abstract available

    December 2016
  6. PECUCHET N, Zonta E, Didelot A, Combe P, et al
    Base-Position Error Rate Analysis of Next-Generation Sequencing Applied to Circulating Tumor DNA in Non-Small Cell Lung Cancer: A Prospective Study.
    PLoS Med. 2016;13:e1002199.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.